{"id":37171,"date":"2021-11-23T10:57:01","date_gmt":"2021-11-23T10:57:01","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=37171"},"modified":"2021-11-23T11:18:25","modified_gmt":"2021-11-23T11:18:25","slug":"greg-hillebrand","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/","title":{"rendered":"Greg Hillebrand"},"content":{"rendered":"
\n\n\t

Greg Hillebrand<\/h2>\n

Senior Principal Research Scientist at Amway<\/h4>\n\t

Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company’s skin and oral microbiome clinical research and product development initiatives.\u00a0 He received his PhD in biochemistry from Baylor College of Medicine in Houston, TX, a postdoc at the University of Illinois, followed by 27 years at Procter & Gamble. He joined Amway in 2012, is currently adjunct professor at the University of Cincinnati Cosmetic Science Program and is on the Scientific Advisory Board for Microbiome Insights in Vancouver.<\/p>\n\t\t\t\t\t\t\t\"Greg_Hillebrand_BioTech_Pharma_Summit_2021_Gallery\"\t\t\t\t\t\t\t\n

\n\tTitle: Topical rosemary extract containing carnosic acid inhibits Staphylococcus aureus virulence in vitro and reduces the signs and symptoms of adult skin irritation and eczema in a randomized, double-blind, vehicle-controlled pilot study.\n\t<\/h3>\n\t

Background: <\/strong>Staphylococcus aureus<\/em> colonization and biofilm formation are directly associated with eczema flares and remission.\u00a0 Expression of the S. aureus<\/em> accessory gene regulator (agr) and quorum sensing are necessary virulence factors.\u00a0\u00a0 Carnosic acid and carnosol, diterpenes found at high levels in Rosmarinus plant species, are potent agr<\/em> expression inhibitors in vitro <\/em>at concentrations as low as 5 \u03bcM.<\/p>\n

\n\t\t\t\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t

https:\/\/www.amway.com\/<\/a><\/p>\n

\n\t\t\t\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t

Visit Profile<\/a><\/p>\n\n<\/div>","protected":false},"excerpt":{"rendered":"

Greg Hillebrand Senior Principal Research Scientist at Amway Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company’s skin and oral microbiome clinical research and product development initiatives.\u00a0 He received his PhD in biochemistry from Baylor College of Medicine in Houston, TX, a postdoc at the University…<\/p>\n","protected":false},"author":1,"featured_media":37175,"parent":32163,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-37171","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nGreg Hillebrand • BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company\u2019s skin and oral microbiome clinical research and product development initiatives.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Greg Hillebrand • BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company\u2019s skin and oral microbiome clinical research and product development initiatives.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-23T11:18:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Profile.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/\",\"name\":\"Greg Hillebrand • BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Profile.jpg\",\"datePublished\":\"2021-11-23T10:57:01+00:00\",\"dateModified\":\"2021-11-23T11:18:25+00:00\",\"description\":\"Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company\u2019s skin and oral microbiome clinical research and product development initiatives.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Profile.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Profile.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Probiotics, Human & Skin Microbiome Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Greg Hillebrand\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow's healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Greg Hillebrand • BioTech Pharma Summit","description":"Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company\u2019s skin and oral microbiome clinical research and product development initiatives.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/","og_locale":"en_US","og_type":"article","og_title":"Greg Hillebrand • BioTech Pharma Summit","og_description":"Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company\u2019s skin and oral microbiome clinical research and product development initiatives.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-11-23T11:18:25+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Profile.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/","name":"Greg Hillebrand • BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Profile.jpg","datePublished":"2021-11-23T10:57:01+00:00","dateModified":"2021-11-23T11:18:25+00:00","description":"Greg Hillebrand is a Senior Principal Research Scientist for Amway where he provides technical leadership for the company\u2019s skin and oral microbiome clinical research and product development initiatives.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Profile.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2021\/11\/Greg_Hillebrand_BioTech_Pharma_Summit_2021_Profile.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/greg-hillebrand\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Probiotics, Human & Skin Microbiome Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/probiotics-human-skin-microbiome-speakers\/"},{"@type":"ListItem","position":3,"name":"Greg Hillebrand"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow's healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=37171"}],"version-history":[{"count":5,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37171\/revisions"}],"predecessor-version":[{"id":37184,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/37171\/revisions\/37184"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32163"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/37175"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=37171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}